Logo image of CGNX

COGNEX CORP (CGNX) Stock Fundamental Analysis

USA - NASDAQ:CGNX - US1924221039 - Common Stock

45.52 USD
-0.91 (-1.96%)
Last: 9/24/2025, 8:00:00 PM
45.12 USD
-0.4 (-0.88%)
After Hours: 9/24/2025, 8:00:00 PM
Fundamental Rating

6

Taking everything into account, CGNX scores 6 out of 10 in our fundamental rating. CGNX was compared to 124 industry peers in the Electronic Equipment, Instruments & Components industry. CGNX has an excellent financial health rating, but there are some minor concerns on its profitability. CGNX is quite expensive at the moment. It does show a decent growth rate.


Dividend Valuation Growth Profitability Health

6

1. Profitability

1.1 Basic Checks

CGNX had positive earnings in the past year.
In the past year CGNX had a positive cash flow from operations.
CGNX had positive earnings in each of the past 5 years.
Each year in the past 5 years CGNX had a positive operating cash flow.
CGNX Yearly Net Income VS EBIT VS OCF VS FCFCGNX Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 100M 200M 300M

1.2 Ratios

The Return On Assets of CGNX (6.09%) is better than 79.84% of its industry peers.
CGNX's Return On Equity of 8.10% is fine compared to the rest of the industry. CGNX outperforms 68.55% of its industry peers.
With a decent Return On Invested Capital value of 5.98%, CGNX is doing good in the industry, outperforming 64.52% of the companies in the same industry.
Measured over the past 3 years, the Average Return On Invested Capital for CGNX is in line with the industry average of 9.48%.
Industry RankSector Rank
ROA 6.09%
ROE 8.1%
ROIC 5.98%
ROA(3y)7.31%
ROA(5y)9.14%
ROE(3y)9.83%
ROE(5y)12.61%
ROIC(3y)7.69%
ROIC(5y)9.5%
CGNX Yearly ROA, ROE, ROICCGNX Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 5 10 15 20

1.3 Margins

The Profit Margin of CGNX (13.13%) is better than 90.32% of its industry peers.
CGNX's Profit Margin has declined in the last couple of years.
With an excellent Operating Margin value of 14.19%, CGNX belongs to the best of the industry, outperforming 87.10% of the companies in the same industry.
CGNX's Operating Margin has declined in the last couple of years.
CGNX has a Gross Margin of 67.72%. This is amongst the best in the industry. CGNX outperforms 97.58% of its industry peers.
CGNX's Gross Margin has declined in the last couple of years.
Industry RankSector Rank
OM 14.19%
PM (TTM) 13.13%
GM 67.72%
OM growth 3Y-25.46%
OM growth 5Y-8.53%
PM growth 3Y-24.51%
PM growth 5Y-16.2%
GM growth 3Y-2.25%
GM growth 5Y-1.51%
CGNX Yearly Profit, Operating, Gross MarginsCGNX Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 20 40 60

9

2. Health

2.1 Basic Checks

CGNX has a Return on Invested Capital (ROIC), which is below the Cost of Capital (WACC), which means it is destroying value.
The number of shares outstanding for CGNX has been reduced compared to 1 year ago.
The number of shares outstanding for CGNX has been reduced compared to 5 years ago.
CGNX has no outstanding debt. Therefor its Debt/Equity and Debt/FCF ratios are 0 and belong to the best of the industry.
CGNX Yearly Shares OutstandingCGNX Yearly Shares OutstandingYearly Shares Outstanding 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 50M 100M 150M
CGNX Yearly Total Debt VS Total AssetsCGNX Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 500M 1B 1.5B 2B

2.2 Solvency

CGNX has an Altman-Z score of 10.65. This indicates that CGNX is financially healthy and has little risk of bankruptcy at the moment.
With an excellent Altman-Z score value of 10.65, CGNX belongs to the best of the industry, outperforming 90.32% of the companies in the same industry.
CGNX has no outstanding debt. Therefor its Debt/Equity and Debt/FCF ratios are 0 and belong to the best of the industry.
Industry RankSector Rank
Debt/Equity 0
Debt/FCF 0
Altman-Z 10.65
ROIC/WACC0.64
WACC9.38%
CGNX Yearly LT Debt VS Equity VS FCFCGNX Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 500M 1B 1.5B

2.3 Liquidity

CGNX has a Current Ratio of 3.29. This indicates that CGNX is financially healthy and has no problem in meeting its short term obligations.
Looking at the Current ratio, with a value of 3.29, CGNX is in the better half of the industry, outperforming 68.55% of the companies in the same industry.
A Quick Ratio of 2.53 indicates that CGNX has no problem at all paying its short term obligations.
CGNX's Quick ratio of 2.53 is fine compared to the rest of the industry. CGNX outperforms 67.74% of its industry peers.
Industry RankSector Rank
Current Ratio 3.29
Quick Ratio 2.53
CGNX Yearly Current Assets VS Current LiabilitesCGNX Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 200M 400M 600M

6

3. Growth

3.1 Past

CGNX shows a strong growth in Earnings Per Share. In the last year, the EPS has been growing by 32.79%, which is quite impressive.
CGNX shows a decrease in Earnings Per Share. Measured over the last years, the EPS has been decreasing by -2.03% yearly.
Looking at the last year, CGNX shows a quite strong growth in Revenue. The Revenue has grown by 10.14% in the last year.
Measured over the past years, CGNX shows a small growth in Revenue. The Revenue has been growing by 4.74% on average per year.
EPS 1Y (TTM)32.79%
EPS 3Y-20.81%
EPS 5Y-2.03%
EPS Q2Q%8.7%
Revenue 1Y (TTM)10.14%
Revenue growth 3Y-4.11%
Revenue growth 5Y4.74%
Sales Q2Q%4.1%

3.2 Future

CGNX is expected to show a strong growth in Earnings Per Share. In the coming years, the EPS will grow by 28.85% yearly.
Based on estimates for the next years, CGNX will show a quite strong growth in Revenue. The Revenue will grow by 9.74% on average per year.
EPS Next Y26.38%
EPS Next 2Y26.35%
EPS Next 3Y24.65%
EPS Next 5Y28.85%
Revenue Next Year6.79%
Revenue Next 2Y8.19%
Revenue Next 3Y8.6%
Revenue Next 5Y9.74%

3.3 Evolution

The EPS growth rate is accelerating: in the next years the growth will be better than in the last years.
When comparing the Revenue growth rate of the last years to the growth rate of the upcoming years, we see that the growth is accelerating.
CGNX Yearly Revenue VS EstimatesCGNX Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 2029 2030 500M 1B
CGNX Yearly EPS VS EstimatesCGNX Yearly EPS VS EstimatesYearly EPS VS Estimates 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 0.5 1 1.5 2

3

4. Valuation

4.1 Price/Earnings Ratio

A Price/Earnings ratio of 56.20 indicates a quite expensive valuation of CGNX.
CGNX's Price/Earnings is on the same level as the industry average.
When comparing the Price/Earnings ratio of CGNX to the average of the S&P500 Index (27.29), we can say CGNX is valued expensively.
A Price/Forward Earnings ratio of 38.53 indicates a quite expensive valuation of CGNX.
The rest of the industry has a similar Price/Forward Earnings ratio as CGNX.
CGNX is valuated expensively when we compare the Price/Forward Earnings ratio to 22.80, which is the current average of the S&P500 Index.
Industry RankSector Rank
PE 56.2
Fwd PE 38.53
CGNX Price Earnings VS Forward Price EarningsCGNX Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 10 20 30 40 50

4.2 Price Multiples

CGNX's Enterprise Value to EBITDA ratio is in line with the industry average.
Based on the Price/Free Cash Flow ratio, CGNX is valued a bit cheaper than the industry average as 65.32% of the companies are valued more expensively.
Industry RankSector Rank
P/FCF 42.55
EV/EBITDA 45.53
CGNX Per share dataCGNX EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 2 4 6 8

4.3 Compensation for Growth

The high PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates CGNX does not grow enough to justify the current Price/Earnings ratio.
CGNX has a very decent profitability rating, which may justify a higher PE ratio.
A more expensive valuation may be justified as CGNX's earnings are expected to grow with 24.65% in the coming years.
PEG (NY)2.13
PEG (5Y)N/A
EPS Next 2Y26.35%
EPS Next 3Y24.65%

5

5. Dividend

5.1 Amount

With a yearly dividend of 0.69%, CGNX is not a good candidate for dividend investing.
CGNX's Dividend Yield is rather good when compared to the industry average which is at 2.22. CGNX pays more dividend than 83.87% of the companies in the same industry.
Compared to an average S&P500 Dividend Yield of 2.38, CGNX's dividend is way lower than the S&P500 average.
Industry RankSector Rank
Dividend Yield 0.69%

5.2 History

The dividend of CGNX is nicely growing with an annual growth rate of 8.39%!
CGNX has been paying a dividend for at least 10 years, so it has a reliable track record.
CGNX has not decreased its dividend in the last 3 years.
Dividend Growth(5Y)8.39%
Div Incr Years3
Div Non Decr Years3
CGNX Yearly Dividends per shareCGNX Yearly Dividends per shareYearly Dividends per share 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 0.5 1 1.5 2

5.3 Sustainability

CGNX pays out 43.88% of its income as dividend. This is a bit on the high side, but may be sustainable.
CGNX's earnings are growing more than its dividend. This makes the dividend growth sustainable.
DP43.88%
EPS Next 2Y26.35%
EPS Next 3Y24.65%
CGNX Yearly Income VS Free CF VS DividendCGNX Yearly Income VS Free CF VS DividendYearly Income VS Free CF VS Dividend 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 100M 200M 300M
CGNX Dividend Payout.CGNX Dividend Payout, showing the Payout Ratio.CGNX Dividend Payout.PayoutRetained Earnings

COGNEX CORP

NASDAQ:CGNX (9/24/2025, 8:00:00 PM)

After market: 45.12 -0.4 (-0.88%)

45.52

-0.91 (-1.96%)

Chartmill FA Rating
GICS IndustryGroupTechnology Hardware & Equipment
GICS IndustryElectronic Equipment, Instruments & Components
Earnings (Last)07-30 2025-07-30/amc
Earnings (Next)10-28 2025-10-28/bmo
Inst Owners101.95%
Inst Owner Change-0.67%
Ins Owners0.27%
Ins Owner Change0.04%
Market Cap7.64B
Analysts76.92
Price Target47.27 (3.84%)
Short Float %3.64%
Short Ratio2.95
Dividend
Industry RankSector Rank
Dividend Yield 0.69%
Yearly Dividend0.31
Dividend Growth(5Y)8.39%
DP43.88%
Div Incr Years3
Div Non Decr Years3
Ex-Date08-14 2025-08-14 (0.08)
Surprises & Revisions
EPS beat(2)2
Avg EPS beat(2)11.3%
Min EPS beat(2)3.71%
Max EPS beat(2)18.89%
EPS beat(4)4
Avg EPS beat(4)13.13%
Min EPS beat(4)3.71%
Max EPS beat(4)26.05%
EPS beat(8)8
Avg EPS beat(8)15.9%
EPS beat(12)11
Avg EPS beat(12)18.09%
EPS beat(16)13
Avg EPS beat(16)14.9%
Revenue beat(2)0
Avg Revenue beat(2)-0.67%
Min Revenue beat(2)-0.78%
Max Revenue beat(2)-0.55%
Revenue beat(4)1
Avg Revenue beat(4)-0.13%
Min Revenue beat(4)-1.24%
Max Revenue beat(4)2.05%
Revenue beat(8)4
Avg Revenue beat(8)0.37%
Revenue beat(12)6
Avg Revenue beat(12)0.55%
Revenue beat(16)8
Avg Revenue beat(16)0.52%
PT rev (1m)2.84%
PT rev (3m)26.74%
EPS NQ rev (1m)0.88%
EPS NQ rev (3m)17.4%
EPS NY rev (1m)0.16%
EPS NY rev (3m)7.69%
Revenue NQ rev (1m)0.15%
Revenue NQ rev (3m)4.77%
Revenue NY rev (1m)0.03%
Revenue NY rev (3m)1.15%
Valuation
Industry RankSector Rank
PE 56.2
Fwd PE 38.53
P/S 8.22
P/FCF 42.55
P/OCF 40.06
P/B 5.07
P/tB 7.52
EV/EBITDA 45.53
EPS(TTM)0.81
EY1.78%
EPS(NY)1.18
Fwd EY2.6%
FCF(TTM)1.07
FCFY2.35%
OCF(TTM)1.14
OCFY2.5%
SpS5.54
BVpS8.97
TBVpS6.05
PEG (NY)2.13
PEG (5Y)N/A
Profitability
Industry RankSector Rank
ROA 6.09%
ROE 8.1%
ROCE 7.28%
ROIC 5.98%
ROICexc 6.84%
ROICexgc 9.9%
OM 14.19%
PM (TTM) 13.13%
GM 67.72%
FCFM 19.32%
ROA(3y)7.31%
ROA(5y)9.14%
ROE(3y)9.83%
ROE(5y)12.61%
ROIC(3y)7.69%
ROIC(5y)9.5%
ROICexc(3y)9.56%
ROICexc(5y)11.82%
ROICexgc(3y)12.73%
ROICexgc(5y)15.09%
ROCE(3y)9.35%
ROCE(5y)11.55%
ROICexcg growth 3Y-25.69%
ROICexcg growth 5Y-4.75%
ROICexc growth 3Y-29.85%
ROICexc growth 5Y-7.09%
OM growth 3Y-25.46%
OM growth 5Y-8.53%
PM growth 3Y-24.51%
PM growth 5Y-16.2%
GM growth 3Y-2.25%
GM growth 5Y-1.51%
F-Score7
Asset Turnover0.46
Health
Industry RankSector Rank
Debt/Equity 0
Debt/FCF 0
Debt/EBITDA 0
Cap/Depr 34.24%
Cap/Sales 1.2%
Interest Coverage 250
Cash Conversion 115.96%
Profit Quality 147.18%
Current Ratio 3.29
Quick Ratio 2.53
Altman-Z 10.65
F-Score7
WACC9.38%
ROIC/WACC0.64
Cap/Depr(3y)84%
Cap/Depr(5y)75.71%
Cap/Sales(3y)2.12%
Cap/Sales(5y)1.9%
Profit Quality(3y)103.13%
Profit Quality(5y)109.22%
High Growth Momentum
Growth
EPS 1Y (TTM)32.79%
EPS 3Y-20.81%
EPS 5Y-2.03%
EPS Q2Q%8.7%
EPS Next Y26.38%
EPS Next 2Y26.35%
EPS Next 3Y24.65%
EPS Next 5Y28.85%
Revenue 1Y (TTM)10.14%
Revenue growth 3Y-4.11%
Revenue growth 5Y4.74%
Sales Q2Q%4.1%
Revenue Next Year6.79%
Revenue Next 2Y8.19%
Revenue Next 3Y8.6%
Revenue Next 5Y9.74%
EBIT growth 1Y45.87%
EBIT growth 3Y-28.52%
EBIT growth 5Y-4.2%
EBIT Next Year53.61%
EBIT Next 3Y31.29%
EBIT Next 5Y22.11%
FCF growth 1Y-4.75%
FCF growth 3Y-23.43%
FCF growth 5Y-10.36%
OCF growth 1Y-7.91%
OCF growth 3Y-22%
OCF growth 5Y-10.06%